Teachers Retirement System of The State of Kentucky decreased its position in Envision Healthcare Co. (NYSE:EVHC) by 96.6% during the fourth quarter, Holdings Channel reports. The fund owned 12,800 shares of the company’s stock after selling 364,752 shares during the period. Teachers Retirement System of The State of Kentucky’s holdings in Envision Healthcare were worth $810,000 as of its most recent SEC filing.
Several other large investors have also added to or reduced their stakes in the company. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its stake in Envision Healthcare by 1.5% in the third quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 26,872 shares of the company’s stock worth $598,000 after buying an additional 402 shares during the last quarter. Pacer Advisors Inc. boosted its stake in Envision Healthcare by 7.4% in the third quarter. Pacer Advisors Inc. now owns 7,045 shares of the company’s stock worth $157,000 after buying an additional 484 shares during the last quarter. Suntrust Banks Inc. boosted its stake in Envision Healthcare by 4.8% in the third quarter. Suntrust Banks Inc. now owns 14,349 shares of the company’s stock worth $319,000 after buying an additional 661 shares during the last quarter. Thompson Investment Management Inc. boosted its stake in Envision Healthcare by 8.8% in the third quarter. Thompson Investment Management Inc. now owns 20,675 shares of the company’s stock worth $460,000 after buying an additional 1,675 shares during the last quarter. Finally, BlackRock Japan Co. Ltd boosted its stake in Envision Healthcare by 1.2% in the third quarter. BlackRock Japan Co. Ltd now owns 236,193 shares of the company’s stock worth $5,260,000 after buying an additional 2,814 shares during the last quarter. Institutional investors own 35.96% of the company’s stock.
Envision Healthcare Co. (NYSE:EVHC) opened at 62.09 on Wednesday. The firm’s 50-day moving average price is $67.94 and its 200-day moving average price is $46.62. Envision Healthcare Co. has a 12-month low of $57.32 and a 12-month high of $83.27. The stock’s market cap is $7.22 billion.
Envision Healthcare (NYSE:EVHC) last issued its quarterly earnings results on Tuesday, February 28th. The company reported $1.15 EPS for the quarter, missing analysts’ consensus estimates of $1.24 by $0.09. The company earned $1.39 billion during the quarter, compared to analysts’ expectations of $1.41 billion. Envision Healthcare had a return on equity of 8.05% and a net margin of 6.06%. The business’s quarterly revenue was up 97.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.07 EPS. On average, equities analysts predict that Envision Healthcare Co. will post $1.40 EPS for the current fiscal year.
A number of research firms have recently commented on EVHC. Jefferies Group LLC set a $32.00 target price on Envision Healthcare and gave the stock a “buy” rating in a research note on Sunday, December 4th. Barclays PLC reiterated an “overweight” rating on shares of Envision Healthcare in a research note on Tuesday. Oppenheimer Holdings Inc. upgraded Envision Healthcare from a “market perform” rating to an “outperform” rating and set a $87.00 target price on the stock in a research note on Wednesday, December 7th. They noted that the move was a valuation call. Royal Bank of Canada lifted their target price on Envision Healthcare from $30.00 to $87.00 and gave the stock an “outperform” rating in a research note on Thursday, January 5th. Finally, TheStreet lowered Envision Healthcare from a “b-” rating to a “c+” rating in a report on Thursday, March 9th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the stock. Envision Healthcare currently has an average rating of “Buy” and a consensus price target of $55.80.
In related news, Director John Thomas Gawaluck purchased 1,500 shares of Envision Healthcare stock in a transaction on Friday, March 10th. The stock was acquired at an average price of $66.65 per share, for a total transaction of $99,975.00. Following the completion of the transaction, the director now directly owns 6,080 shares in the company, valued at approximately $405,232. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 2.30% of the company’s stock.
About Envision Healthcare
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare Co. (NYSE:EVHC).